<DOC>
	<DOCNO>NCT01673555</DOCNO>
	<brief_summary>This protocol design explore whether short-term therapy GSK1278863 affect PASP normoxic hypoxic condition healthy volunteer . Healthy subject evaluate use echocardiography estimate PASP base velocity tricuspid regurgitant jet . Resting PASP assess normoxic ( room air ) condition , well 30 minute ' exposure 15 % O2 , , short-term treatment GSK1278863 .</brief_summary>
	<brief_title>Effects GSK1278863A Pulmonary Artery Pressure Healthy Volunteers</brief_title>
	<detailed_description>This single-center , randomize , placebo-controlled , single-blinded ( subject investigator blind , GSK internal personnel blind ) study design test whether short-term administration ( 5 day ) GSK1278863 affect PASP normoxic hypoxic condition healthy volunteer . Approximately 45 healthy subject mild-moderate baseline tricuspid regurgitation ( sufficient allow reliable assessment PASP ) enrol study provide ~15 evaluable subject arm [ Placebo , 5 mg , 100 mg GSK 1278863 ] .</detailed_description>
	<mesh_term>Glycine</mesh_term>
	<criteria>AST , ALT , alkaline phosphatase bilirubin less equal 1.5xULN ( isolate bilirubin great 1.5xULN acceptable bilirubin fractionate direct bilirubin le 35 % ) . Healthy determine responsible experienced physician , base medical evaluation include [ medical history , physical examination laboratory test ] . A subject clinical abnormality laboratory parameter outside reference range population study may include Investigator GSK Medical Monitor agree find unlikely introduce additional risk interfere study procedure . A hemoglobin value screen 13.5 16 g/dL . Male subject 18 55 year age inclusive , time signing informed consent . Male subject female partner childbearing potential must agree use one contraception method list protocol . This criterion must follow time first dose study medication followup visit . BMII le equal 32 kg/m2 Single QTcB QTcF le 450 msec Screening echocardiogram least good quality , without clinically significant abnormality , mildmoderate tricuspid regurgitation sufficient reliable estimation PASP , determine echocardiography core laboratory responsible cardiologist . Screening PASP within normal range normoxic condition . A positive prestudy Hepatitis B surface antigen positive Hepatitis C antibody result . Current chronic history liver disease , know hepatic biliary abnormality ( exception Gilbert 's syndrome asymptomatic gallstone ) . A positive prestudy drug/alcohol screen . Any history IV drug abuse . A positive test HIV antibody . History regular alcohol consumption within 6 month study define : average weekly intake great 14 drink male great 7 drink female . One drink equivalent 12 g alcohol : 12 ounce ( 360 ml ) beer , 5 ounce ( 150 ml ) wine 1.5 ounce ( 45 ml ) 80 proof distil spirit . The subject participate clinical trial receive investigational product within following time period prior first dose day current study : 30 day , 5 halflives twice duration biological effect investigational product ( whichever longer ) . Exposure four new chemical entity within 12 month prior first dose day . Use prescription nonprescription drug , include vitamin , herbal dietary supplement ( include St John 's Wort ) within 7 day ( 14 day drug potential enzyme inducer ) 5 halflives ( whichever longer ) prior first dose study medication , unless opinion Investigator GSK Medical Monitor medication interfere study procedure compromise subject safety . Where participation study would result donation blood blood product excess 500 mL within 56 day period . Unwillingness inability follow procedure outline protocol . Urinary cotinine level indicative smoke history regular use tobacco nicotinecontaining product within 6 month prior screen . Strong family history malignancy . Subjects sickle cell trait . History pulmonary hypertension</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>GSK1278863</keyword>
	<keyword>Pulmonary artery pressure</keyword>
</DOC>